Am J Transplant, Volume 18, Suppl 3 Archives - Page 16 of 211 - ATC Abstracts

2018 American Transplant Congress
Supercooling of Human Livers to Extend the Preservation Time for Transplantation
R. de Vries,^1,2 S. Tessier,^1,2 P. Banik,^1,2 S. Ozer,^1,2 S. Napgal,^1,2 S. Cronin,^1,2 J. Markmann,^1,2 H. Yeh,^1,2 K. Uygun.^1,2
¹Department of Surgery, Massachusetts General Hospital, Boston, MA; ²Center for Engineering in Medicine, Harvard Medical School, Boston, MA.
Introduction: Extending the maximum preservation time of donor organs could dramatically improve the outcome of organ transplantation. Static cold storage (SCS) at +5[deg]C is the…
2018 American Transplant Congress
Shortened Cold Ischemia Time and Reduced Incidence of Delayed Graft Function for Kidney Transplants through Enhanced Tissue Compatibility Testing
I. Helanterä,¹ T. Saarinen,² J. Peräsaari,² M. Lempinen,¹ J. Lauronen.²
¹Transplantation and Liver Surgery, Helsinki University Hospital, Helsinki, Finland; ²Histocompatibility Laboratory, Finnish Red Cross Blood Service, Helsinki, Finland.
A. HLA-typing and prospective leukocyte cross-matching needed for deceased donor kidney transplantation (kTX) may delay the onset of surgery. We compared cold ischemia times (CIT)…
2018 American Transplant Congress
Improvement in Intermediate Graft Survival among Deceased Donor Recipients in the Last Decade Due to Improvements in Outcomes of Higher KDPI Kidney Recipients
D. Keith.
Medicine, Sacred Heart Hospital, Pensacola, FL, Turkey.
Previous research by our group showed that intermediate graft survival of adult deceased donor kidney transplants between six months and three years post-transplant improved in…
2018 American Transplant Congress
Long-Term Outcomes of Primary Kidney Transplant from Expanded Criteria Maastricht Category 3 DCD Donors: A Single-Centre Observational Study
E. Favi,¹ C. Puliatti,² S. Iesari,³ M. Ferraresso,¹ R. Cacciola.²
¹Kidney Transplantation, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy; ²Kidney Transplantation, The Royal London Hospital, London, United Kingdom; ³Kidney Transplantation, University of L'Aquila, L'Aquila, Italy.
Background. Kidney transplants (KTx) from standard (STD) DCD donors have higher rates of primary non function (PNF) and delayed graft function (DGF) than DBD but…
2018 American Transplant Congress
The Association between Transplant Glomerulopathy and Graft Outcomes among Patients Undergoing Kidney Transplantation: Results of a Meta-Analysis
G. Kovács,¹ G. Devercelli,² Z. Vokó,^1,3 T. Zelei,¹ I. Hirji,² P. Keown.^4,5
¹Syreon Research Institute, Budapest, Hungary; ²Shire, Lexington, MA; ³Health Policy & Health Economics, Eötvös Loránd University, Budapest, Hungary; ⁴Syreon Corporation, Vancouver, BC, Canada; ⁵University of British Columbia, Vancouver, BC, Canada.
Transplant glomerulopathy (TG) can lead to irreversible kidney damage. TG is recognized as a surrogate marker for poor outcomes, including graft failure and loss among…
2018 American Transplant Congress
Equivalent Clinical Outcomes and Stable Post-Operative Anti-A IgG Titers in A2 to B Renal Transplant Recipients Compared to Matched B to B Cohort
C. Barnhill,¹ P. Warner,² A. Weiss,¹ C. Kuhr,¹ N. Cowan,¹ J. Brandenberger.¹
¹Transplant, Virginia Mason Medical Center, Seattle; ²Immunogenetics/HLA Laboratory, Bloodworks Northwest, Seattle.
With the longest wait times and lowest rate of transplantation, ABO type B renal transplant candidates are at a disadvantage when compared to their type…
2018 American Transplant Congress
Willingness to Consider Increased Risk Donors: A Single Center Experience
V. Richards,¹ C. Johnson,¹ J. Perkins,² A. Limaye,³ L. Sibulesky.²
¹Nephrology, University of Washington, Seattle, WA; ²Surgery, University of Washington, Seattle, WA; ³Allergy and Infectious Diseases, University of Washington, Seattle, WA.
Background: The number of Public Health Service increased risk organ donors (PHS IRD) is growing, largely due to the opioid epidemic.Methods: We conducted a retrospective…
2018 American Transplant Congress
Outcomes of Hispanic Kidney Transplant Recipients under a Cyclosporine versus Tacrolimus Based Immunosuppression Protocol
P. West-Thielke, M. Campara, I. Tang, E. Benedetti.
University of Illinois, Chicago.
Purpose: In 2005, an internal retrospective review of kidney transplant recipients (KTx) showed a higher incidence of post transplant diabetes mellitus (PTDM) for Hispanic patients…
2018 American Transplant Congress
Kidney Related Issues Leads the Medical Reasons to Exclude Potential Living Kidney Donors from Donation ; Prospective Study
H. Al-Eid, N. Sadaqah, I. Ibrahim, S. Aleid, A. Abdulbaki, S. Raza, I. Alahmadi, T. Ali, J. Brockman, D. Broring.
Kidney and Pancreas Transplantation, King Faisal Specialist Hospital, Riyadh, Saudi Arabia.
Living kidney donors provide the best therapeutic option for patients with kidney failure going for kidney transplantation; however significant numbers of them are out for…
2018 American Transplant Congress
Subclinical Borderline Rejection: More Than Meets the Eye?
M. Bernard, G. Agarwal, H. Fatima, B. Julian, C. Kew, V. Kumar, S. Mehta, S. Ong, A. Patel, G. Towns, M. Seifert, R. Mannon.
UAB School of Medicine, Birmingham.
Purpose: Surveillance biopsies can detect subclinical T cell mediated rejection (SC-TCMR) or subclinical borderline rejection (SC-B-TCMR) in patients with normal/stable creatinine, but the impact on…